Biomedical Context Layer Changelog | The Data Developers

Changelog

Product Updates and Data Refreshes

Timeline of source refreshes, feature releases, identity spine updates, and schema improvements.

2026.09 September 1, 2026feature

September 2026 — Drug Identity Spine Expansion

Expanded variant mappings to 567,000+ drug, substance, billing, and chemistry identifiers.
Added improved RxNorm-to-NDC join validation reports.
Published new sample queries for IRA and PV workflows.

Clinical drug naming and RxCUI identity context Packaged product identity and commercial code context Retail-to-medical billing bridge context

2026.07 July 15, 2026data

July 2026 — FAERS Quarterly Refresh + Label Coverage

Loaded latest FAERS quarterly case, drug, reaction, outcome, indication, and therapy tables.
Refreshed PRR signal scoring and unlabeled signal tier flags.
Recomputed label coverage against current and historical FDA labels.

Post-market adverse-event signals and safety reporting context Drug-event disproportionality and label-coverage context Current prescribing context, warnings, indications, and dosing

2026.03 March 4, 2026data

March 2026 — FAERS Q1 Refresh + EMA Update

Updated EMA authorization records and orphan/biosimilar status fields.
Added new coverage metrics for dual-market FDA and EMA product bridges.
Improved biologic reference product linkage for IRA 11-year clock modeling.

European authorization and dual-market context Biologic competition, biosimilar status, and IRA timing Post-market adverse-event signals and safety reporting context